Cargando…

The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score

Objective: This study determined if an accessible, serologic indicator of vascular disease activity, the von Willebrand factor antigen (vWF:Ag), was useful to assess disease activity in children with juvenile dermatomyositis (JDM), a rare disease, but the most common of the pediatric inflammatory my...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibbs, Ellie, Khojah, Amer, Morgan, Gabrielle, Ehwerhemuepha, Louis, Pachman, Lauren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953073/ https://www.ncbi.nlm.nih.gov/pubmed/36831088 http://dx.doi.org/10.3390/biomedicines11020552

Ejemplares similares

Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers
por: Khojah, Amer, et al.
Publicado: (2021)

B Cell Lymphocytosis in Juvenile Dermatomyositis
por: Costin, Christopher, et al.
Publicado: (2023)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
por: Pachman, Lauren M., et al.
Publicado: (2023)

Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
por: Costin, Christopher, et al.
Publicado: (2023)

Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids
por: Khojah, Amer, et al.
Publicado: (2021)

Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
por: Pachman, Lauren M., et al.
Publicado: (2021)

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study
por: Ochfeld, Elisa, et al.
Publicado: (2022)

Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study
por: Bukhari, Ameera, et al.
Publicado: (2023)

Serum protein biomarkers for juvenile dermatomyositis: a pilot study
por: Tawalbeh, Shefa M., et al.
Publicado: (2020)

Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study
por: Xu, Dong, et al.
Publicado: (2017)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
por: Roberson, Elisha D. O., et al.
Publicado: (2022)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975)

3233 Von Willebrand Factor is Localized in the Extravascular tissue of Patients with Juvenile Scleroderma
por: Canizares, Natalia Vasquez, et al.
Publicado: (2019)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
por: Chen, Yi-Wen, et al.
Publicado: (2008)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
por: Wienke, Judith, et al.
Publicado: (2020)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
por: Conklin, Laurie S., et al.
Publicado: (2018)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2021)

Von Willebrand Factor, Angiodysplasia and Angiogenesis
por: Randi, Anna M., et al.
Publicado: (2013)

Regulation of plasma von Willebrand factor
por: Desch, Karl C
Publicado: (2018)

Plasma fibrinolysis is related to the SOFA score but not to the von Willebrand factor on ICU admission
por: Boudjeltia, K Zouaoui, et al.
Publicado: (2008)

Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)

Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores
por: Belen Apak, Fatma Burcu, et al.
Publicado: (2020)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
por: Casonato, Alessandra, et al.
Publicado: (2021)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u8o0qjepu71c5ck9p14ttbh60p